CAMBRIDGE, Mass., June 01, 2016 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the
fields of cancer metabolism and rare genetic metabolic disorders, today announced that the company will host a conference call and
live webcast on Saturday, June 11, 2016 at 9:30 a.m. ET to discuss clinical and preclinical data presented at the 21st Congress of
the European Hematology Association (EHA) taking place June 9-12, 2016 in Copenhagen.
The live webcast can be accessed under "Events & Presentations" in the Investors and Media section of the company's website at
www.agios.com. The conference call can be accessed by dialing 1-877-377-7098 (domestic) or
1-631-291-4547 (international) and referring to conference ID 18475657. The webcast will be archived and made available for replay
on the company's website beginning approximately two hours after the event.
About Agios
Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic metabolic
disorders through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery
pipeline across both therapeutic areas, Agios has multiple first-in-class investigational medicines in clinical and/or preclinical
development. All Agios programs focus on genetically identified patient populations, leveraging our knowledge of metabolism,
biology and genomics. For more information, please visit the company's website at www.agios.com.
Contact:
Renee Leck, Senior Manager, Investor & Public Relations
Renee.Leck@agios.com
617-649-8299
